During the past decade, C.H. Senlis conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "C.H. Senlis" #1 sponsor was "GERCOR - Multidisciplinary Oncology Cooperative Group" with 20 trials, followed by "UNICANCER" with 5 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Centre Hospitalier Universitaire, Amiens" with 3 trials sponsored and "Federation Francophone de Cancerologie Digestive" with 3 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "C.H. Senlis" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "Faculté de mathématiques ORLEANS" with 1 trials as a collaborator, "Fondation de France" with 1 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 1 trials as a collaborator and "Groupe Francais De Pneumo-Cancerologie" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "C.H. Senlis" are "Breast Cancer" (9 trials), "Colorectal Cancer" (8 trials), "Pancreatic Cancer" (4 trials), "Esophageal Cancer" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "C.H. Senlis" in a lesser frequency.

Most popular intervention types in "C.H. Senlis" are "Drug" (32 trials), "Other" (8 trials), "Procedure" (7 trials), "Radiation" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (8 trials), "oxaliplatin" (8 trials), "gemcitabine hydrochloride" (5 trials), "leucovorin calcium" (5 trials) and "radiation therapy" (5 trials). Other intervention names were less common.

The vast majority of trials in "C.H. Senlis" are 31 trials for "All" genders, 11 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "C.H. Senlis". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in C.H. Senlis, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in C.H. Senlis, 2 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".

C.H. Senlis has several departments that took part in Clinical trials: "Ch Laennec; Nephrologie Hemodialyse" - 2 trials